Back to search
FDAFDA · Food and drugs·Recall number Z-1336-2023

VASOVIEW HEMOPRO 2 Endoscopic Vessel Harvesting System, Model Number C-VH-4000

Published April 12, 2023 · Recall initiated: March 6, 2023

Summary

FDA records medical device Class II recall Z-1336-2023, published April 12, 2023 and initiated March 6, 2023. Recalling firm: Maquet Cardiovascular, LLC; Status: Ongoing; Reported quantity: 2300 units; Lot: UDI-DI: 00607567700406; Lot Numbers: 3000278401, 3000271148, 3000268643, 3000263026, 3000274504, 3000263925. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Some batches of product were not sterilized to their minimum sterilization specification.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Maquet Cardiovascular, LLC
Distributor
Worldwide distribution - US Nationwide and the countries of Brazil, China.
Lot
UDI-DI: 00607567700406; Lot Numbers: 3000278401, 3000271148, 3000268643, 3000263026, 3000274504, 3000263925
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was VASOVIEW HEMOPRO 2 Endoscopic Vessel Harvesting System, Model Number C-VH-4000 recalled?

Yes. FDA published recall Z-1336-2023 on April 12, 2023. Reported hazard: Some batches of product were not sterilized to their minimum sterilization specification.

What should I do if I have this product?

Voluntary: Firm initiated · Letter